Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Italmed S.r.l. (also known as Italmed-Ad S.r.l.) is an Italian medical device and biotechnology company based in Florence, specializing in the research, development, and patenting of innovative oral care and dental surgery products. The company focuses on periodontology, endodontics, and restorative surgery, developing Class III medical devices and local drug delivery systems. Its flagship products include Gelcide and Implaprotect, which utilize a patented local delivery system combining the antibiotics piperacillin and tazobactam to treat periodontitis and peri-implantitis. Additionally, Italmed manufactures Biotivity Hyaluronic Acid, which is distributed globally by ZimVie to facilitate bone and soft tissue healing during dental procedures. The company collaborates with prominent Italian and European universities to conduct preclinical and clinical studies, offering turnkey private-label manufacturing and distribution partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Italmed.